| Year |
Citation |
Score |
| 2024 |
Costa-Guda J, Cohen ST, Romano R, Acostamadiedo J, Clark K, Bellizzi J, Arnold A. Phenotype of Parathyroid-targeted Deletion in Mice Is Strain-dependent. Journal of the Endocrine Society. 8: bvae006. PMID 38328479 DOI: 10.1210/jendso/bvae006 |
0.311 |
|
| 2023 |
Costa-Guda J, Corrado K, Bellizzi J, Saria E, Saucier K, Guemes-Aragon M, Kakar G, Rose M, Pascal M, Alander C, Mallya SM, Arnold A. Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid Tumorigenesis. Endocrinology. PMID 37694586 DOI: 10.1210/endocr/bqad137 |
0.313 |
|
| 2021 |
Brewer K, Nip I, Bellizzi J, Costa-Guda J, Arnold A. Molecular analysis of cyclin D1 modulators PRKN and FBX4 as candidate tumor suppressors in sporadic parathyroid adenomas. Endocrine Connections. 10: 302-308. PMID 33617468 DOI: 10.1530/EC-21-0055 |
0.375 |
|
| 2020 |
Costa-Guda J, Corrado K, Bellizzi J, Romano R, Saria E, Saucier K, Rose M, Shah S, Alander C, Mallya S, Arnold A. CDK4/6 Dependence of Cyclin D1-driven Parathyroid Neoplasia In Transgenic Mice. Endocrinology. PMID 32877917 DOI: 10.1210/Endocr/Bqaa159 |
0.37 |
|
| 2019 |
Riccardi A, Aspir T, Shen L, Kuo CL, Brown TC, Korah R, Murtha TD, Bellizzi J, Parham K, Carling T, Costa-Guda J, Arnold A. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas. The Journal of Clinical Endocrinology and Metabolism. PMID 30624640 DOI: 10.1210/Jc.2018-02517 |
0.363 |
|
| 2019 |
Brewer K, Costa-Guda J, Arnold A. Molecular genetic insights into sporadic primary hyperparathyroidism. Endocrine-Related Cancer. 26: R53-R72. PMID 30475215 DOI: 10.1530/Erc-18-0304 |
0.456 |
|
| 2017 |
Romano R, Ellis S, Yu N, Bellizzi J, Brown TC, Korah R, Carling T, Costa-Guda J, Arnold A. Mutational Analysis of ZFY in Sporadic Parathyroid Adenomas. Journal of the Endocrine Society. 1: 313-316. PMID 29264489 DOI: 10.1210/Js.2017-00031 |
0.396 |
|
| 2017 |
Pandya C, Uzilov AV, Bellizzi J, Lau CY, Moe AS, Strahl M, Hamou W, Newman LC, Fink MY, Antipin Y, Yu W, Stevenson M, Cavaco BM, Teh BT, Thakker RV, ... ... Arnold A, et al. Genomic profiling reveals mutational landscape in parathyroid carcinomas. Jci Insight. 2: e92061. PMID 28352668 DOI: 10.1172/Jci.Insight.92061 |
0.405 |
|
| 2016 |
Arnold A. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM. Transactions of the American Clinical and Climatological Association. 127: 235-244. PMID 28066056 |
0.31 |
|
| 2016 |
Romano R, Soong CP, Rose M, Costa-Guda J, Bellizzi J, Arnold A. EZH2 copy number and mutational analyses in sporadic parathyroid adenomas. Endocrine. PMID 27738890 DOI: 10.1007/S12020-016-1142-Z |
0.308 |
|
| 2016 |
Mallya SM, Corrado KR, Saria EA, Yuan FF, Tran HQ, Saucier K, Atti E, Tetradis S, Arnold A. Modeling vitamin D insufficiency and moderate deficiency in adult mice via dietary cholecalciferol restriction. Endocrine Research. 1-10. PMID 26906176 DOI: 10.3109/07435800.2016.1141937 |
0.32 |
|
| 2016 |
Brewer K, Costa-Guda J, Arnold A. Abstract 3653: Mutational analysis of PARK2, a regulator of cyclin D1 stability, in sporadic parathyroid adenoma Cancer Research. 76: 3653-3653. DOI: 10.1158/1538-7445.Am2016-3653 |
0.493 |
|
| 2015 |
Casimiro MC, Arnold A, Pestell RG. Kinase independent oncogenic cyclin D1. Aging. 7: 455-6. PMID 26187783 |
0.479 |
|
| 2015 |
Casimiro MC, Di Sante G, Crosariol M, Loro E, Dampier W, Ertel A, Yu Z, Saria EA, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti MP, Fortina P, Cardiff RD, ... ... Arnold A, et al. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. Oncotarget. 6: 8525-38. PMID 25940700 DOI: 10.18632/Oncotarget.3267 |
0.585 |
|
| 2015 |
Corrado KR, Andrade SC, Bellizzi J, D'Souza-Li L, Arnold A. Polyclonality of Parathyroid Tumors in Neonatal Severe Hyperparathyroidism. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 25828954 DOI: 10.1002/Jbmr.2516 |
0.409 |
|
| 2014 |
Arnold A, Soong CP. New role for ZFX in oncogenesis. Cell Cycle (Georgetown, Tex.). 13: 3465-6. PMID 25493409 DOI: 10.4161/15384101.2014.980693 |
0.508 |
|
| 2014 |
Costa-Guda J, Arnold A. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors. Molecular and Cellular Endocrinology. 386: 46-54. PMID 24035866 DOI: 10.1016/J.Mce.2013.09.005 |
0.465 |
|
| 2013 |
Costa-Guda J, Soong CP, Parekh VI, Agarwal SK, Arnold A. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas. Hormones & Cancer. 4: 301-7. PMID 23715670 DOI: 10.1007/S12672-013-0147-9 |
0.43 |
|
| 2013 |
Costa-Guda J, Imanishi Y, Palanisamy N, Kawamata N, Phillip Koeffler H, Chaganti RS, Arnold A. Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins. Endocrine. 44: 489-95. PMID 23435613 DOI: 10.1007/S12020-013-9903-4 |
0.406 |
|
| 2013 |
Pestell R, Casimiro M, Crosariol M, Loro E, Dampier W, Sante GD, Ertel A, Yu Z, Saria E, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti M, Fortina P, ... ... Arnold A, et al. Abstract P5-07-06: Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-07-06 |
0.613 |
|
| 2012 |
Casimiro MC, Crosariol M, Loro E, Ertel A, Yu Z, Dampier W, Saria EA, Papanikolaou A, Stanek TJ, Li Z, Wang C, Fortina P, Addya S, Tozeren A, Knudsen ES, ... Arnold A, et al. ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice. The Journal of Clinical Investigation. 122: 833-43. PMID 22307325 DOI: 10.1172/Jci60256 |
0.609 |
|
| 2011 |
Imanishi Y, Kawata T, Kenko T, Wada M, Nagano N, Miki T, Arnold A, Inaba M. Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism. Calcified Tissue International. 89: 29-35. PMID 21541686 DOI: 10.1007/S00223-011-9490-4 |
0.345 |
|
| 2011 |
Costa-Guda J, Marinoni I, Molatore S, Pellegata NS, Arnold A. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas. The Journal of Clinical Endocrinology and Metabolism. 96: E701-6. PMID 21289244 DOI: 10.1210/Jc.2010-1338 |
0.449 |
|
| 2011 |
Juhlin CC, Haglund F, Obara T, Arnold A, Larsson C, Höög A. Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours. Virchows Archiv : An International Journal of Pathology. 459: 47-53. PMID 21221636 DOI: 10.1007/S00428-010-1032-3 |
0.356 |
|
| 2010 |
Mallya SM, Wu HI, Saria EA, Corrado KR, Arnold A. Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 25: 2606-12. PMID 20641034 DOI: 10.1002/Jbmr.187 |
0.457 |
|
| 2009 |
Radaelli E, Arnold A, Papanikolaou A, Garcia-Fernandez RA, Mattiello S, Scanziani E, Cardiff RD. Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas. Veterinary Pathology. 46: 736-745. PMID 19276050 DOI: 10.1354/Vp.08-Vp-0280-R-Fl |
0.358 |
|
| 2009 |
Lauter K, Arnold A. Analysis of CYP27B1, encoding 25-hydroxyvitamin D-1alpha-hydroxylase, as a candidate tumor suppressor gene in primary and severe secondary/tertiary hyperparathyroidism. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 24: 102-4. PMID 18767934 DOI: 10.1359/Jbmr.080903 |
0.505 |
|
| 2008 |
Lauter KB, Arnold A. Mutational analysis of CDKN1B, a candidate tumor-suppressor gene, in refractory secondary/tertiary hyperparathyroidism. Kidney International. 73: 1137-40. PMID 18288099 DOI: 10.1038/Ki.2008.28 |
0.427 |
|
| 2007 |
Costa-Guda J, Tokura T, Roth SI, Arnold A. Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas. Bmc Endocrine Disorders. 7: 8. PMID 17916247 DOI: 10.1186/1472-6823-7-8 |
0.338 |
|
| 2007 |
Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M, Nishizawa Y. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. Journal of the American Society of Nephrology : Jasn. 18: 2683-8. PMID 17855636 DOI: 10.1681/Asn.2006070783 |
0.313 |
|
| 2007 |
Juhlin CC, Villablanca A, Sandelin K, Haglund F, Nordenström J, Forsberg L, Bränström R, Obara T, Arnold A, Larsson C, Höög A. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocrine-Related Cancer. 14: 501-12. PMID 17639063 DOI: 10.1677/Erc-07-0021 |
0.391 |
|
| 2007 |
Costa-Guda J, Arnold A. Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. The Journal of Clinical Endocrinology and Metabolism. 92: 1564-6. PMID 17284619 DOI: 10.1210/Jc.2006-2554 |
0.322 |
|
| 2006 |
Costa-Guda J, Lauter K, Naveh-Many T, Silver J, Arnold A. Mutational analysis of the PTH 3'-untranslated region in parathyroid disorders. Clinical Endocrinology. 65: 806-9. PMID 17121534 DOI: 10.1111/J.1365-2265.2006.02670.X |
0.391 |
|
| 2006 |
Samander EH, Arnold A. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas. The Journal of Clinical Endocrinology and Metabolism. 91: 5019-21. PMID 17003089 DOI: 10.1210/Jc.2006-1543 |
0.464 |
|
| 2006 |
Kelly TG, Shattuck TM, Reyes-Mugica M, Stewart AF, Simonds WF, Udelsman R, Arnold A, Carpenter TO. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 21: 1666-71. PMID 16995822 DOI: 10.1359/Jbmr.060702 |
0.36 |
|
| 2006 |
Lafferty FW, Hamlin CR, Corrado KR, Arnold A, Shuck JM. Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves Journal of Clinical Endocrinology and Metabolism. 91: 3826-3829. PMID 16849415 DOI: 10.1210/Jc.2006-0273 |
0.31 |
|
| 2006 |
Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, Wang C, Byers S, Nicholson R, Link T, Shemluck M, ... ... Arnold A, et al. Cyclin D1 determines mitochondrial function in vivo. Molecular and Cellular Biology. 26: 5449-69. PMID 16809779 DOI: 10.1128/Mcb.02074-05 |
0.589 |
|
| 2006 |
Jiménez C, Cote G, Arnold A, Gagel RF. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? The Journal of Clinical Endocrinology and Metabolism. 91: 2851-8. PMID 16735498 DOI: 10.1210/Jc.2005-2178 |
0.33 |
|
| 2006 |
VanHouten JN, Yu N, Rimm D, Dotto J, Arnold A, Wysolmerski JJ, Udelsman R. Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene Journal of Clinical Endocrinology and Metabolism. 91: 580-583. PMID 16263810 DOI: 10.1210/Jc.2005-2095 |
0.36 |
|
| 2005 |
Kawata T, Imanishi Y, Kobayashi K, Kenko T, Wada M, Ishimura E, Miki T, Nagano N, Inaba M, Arnold A, Nishizawa Y. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism. European Journal of Endocrinology. 153: 587-94. PMID 16189180 DOI: 10.1530/Eje.1.02007 |
0.321 |
|
| 2005 |
Arnold A, Papanikolaou A. Cyclin D1 in breast cancer pathogenesis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4215-24. PMID 15961768 DOI: 10.1200/Jco.2005.05.064 |
0.454 |
|
| 2005 |
Krebs LJ, Shattuck TM, Arnold A. HRPT2 mutational analysis of typical sporadic parathyroid adenomas. The Journal of Clinical Endocrinology and Metabolism. 90: 5015-7. PMID 15956079 DOI: 10.1210/Jc.2005-0717 |
0.322 |
|
| 2005 |
Shattuck TM, Westra WH, Ladenson PW, Arnold A. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. The New England Journal of Medicine. 352: 2406-12. PMID 15944425 DOI: 10.1056/Nejmoa044190 |
0.355 |
|
| 2005 |
Mallya SM, Gallagher JJ, Wild YK, Kifor O, Costa-Guda J, Saucier K, Brown EM, Arnold A. Abnormal parathyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism. Molecular Endocrinology (Baltimore, Md.). 19: 2603-9. PMID 15928311 DOI: 10.1210/Me.2005-0116 |
0.402 |
|
| 2005 |
Costa-Guda J, Rosen ED, Jensen RT, Chung DC, Arnold A. Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours. Clinical Endocrinology. 62: 603-6. PMID 15853832 DOI: 10.1111/J.1365-2265.2005.02267.X |
0.385 |
|
| 2003 |
Shattuck TM, Välimäki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. The New England Journal of Medicine. 349: 1722-9. PMID 14585940 DOI: 10.1056/Nejmoa031237 |
0.377 |
|
| 2003 |
Shattuck TM, Kim TS, Costa J, Yandell DW, Imanishi Y, Palanisamy N, Gaz RD, Shoback D, Clark OH, Monchik JM, Wierman ME, Hollenberg A, Tojo K, Chaganti RS, Arnold A. Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma. Clinical Endocrinology. 59: 180-9. PMID 12864795 DOI: 10.1046/J.1365-2265.2003.01814.X |
0.39 |
|
| 2003 |
Mallya SM, Gallagher JJ, Arnold A. Analysis of microsatellite instability in sporadic parathyroid adenomas. The Journal of Clinical Endocrinology and Metabolism. 88: 1248-51. PMID 12629114 DOI: 10.1210/Jc.2002-021455 |
0.341 |
|
| 2002 |
Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y, Saucier K. Molecular pathogenesis of primary hyperparathyroidism. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 17: N30-6. PMID 12412775 DOI: 10.1007/978-1-4614-2164-1_16 |
0.327 |
|
| 2002 |
Shattuck TM, Costa J, Bernstein M, Jensen RT, Chung DC, Arnold A. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors. The Journal of Clinical Endocrinology and Metabolism. 87: 3911-4. PMID 12161532 DOI: 10.1210/Jcem.87.8.8707 |
0.419 |
|
| 2002 |
Imanishi Y, Tahara H, Palanisamy N, Spitalny S, Salusky IB, Goodman W, Brandi ML, Drüeke TB, Sarfati E, Ureña P, Chaganti RS, Arnold A. Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia. Journal of the American Society of Nephrology : Jasn. 13: 1490-8. PMID 12039978 DOI: 10.1097/01.Asn.0000018148.50109.C0 |
0.4 |
|
| 2002 |
Hosokawa Y, Papanikolaou A, Cardiff RD, Yoshimoto K, Bernstein M, Wang TC, Schmidt EV, Arnold A. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53. Transgenic Research. 10: 471-8. PMID 11708657 DOI: 10.1023/A:1012064911751 |
0.429 |
|
| 2002 |
Costa J, Shattuck T, Imanishi Y, Palanisamy N, Gaz R, Shoback D, Clark O, Monchik J, Wierman M, Hollenberg A, Tojo Κ, Chaganti R, Arnold A. Mutational Analyses of Connexin 26, Connexin 30 and Connexin 46 as Candidate Tumor Suppressor Genes in Parathyroid Carcinoma International Journal On Disability and Human Development. 3. DOI: 10.1515/IJDHD.2002.3.2.57 |
0.303 |
|
| 2001 |
Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, ... ... Arnold A, et al. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. The Journal of Clinical Investigation. 107: 1093-102. PMID 11342573 DOI: 10.1172/Jci10523 |
0.472 |
|
| 2000 |
Chung DC, Brown SB, Graeme-Cook F, Seto M, Warshaw AL, Jensen RT, Arnold A. Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. The Journal of Clinical Endocrinology and Metabolism. 85: 4373-8. PMID 11095482 DOI: 10.1210/Jcem.85.11.6937 |
0.456 |
|
| 2000 |
Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. The Journal of Clinical Endocrinology and Metabolism. 85: 1758-64. PMID 10843148 DOI: 10.1210/Jcem.85.5.6557 |
0.358 |
|
| 2000 |
Mallya SM, Arnold A. Cyclin D1 in parathyroid disease. Frontiers in Bioscience : a Journal and Virtual Library. 5: D367-71. PMID 10704427 DOI: 10.2741/Mallya |
0.516 |
|
| 2000 |
Brown SB, Brierley TT, Palanisamy N, Salusky IB, Goodman W, Brandi ML, Drüeke TB, Sarfati E, Ureña P, Chaganti RS, Pike JW, Arnold A. Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia. The Journal of Clinical Endocrinology and Metabolism. 85: 868-72. PMID 10690903 DOI: 10.1210/Jcem.85.2.6426 |
0.468 |
|
| 2000 |
Carling T, Imanishi Y, Gaz RD, Arnold A. RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutations. Clinical Endocrinology. 51: 403-7. PMID 10583305 DOI: 10.1046/J.1365-2265.1999.00779.X |
0.374 |
|
| 1999 |
Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocrine Reviews. 20: 501-34. PMID 10453356 DOI: 10.1210/Edrv.20.4.0373 |
0.708 |
|
| 1999 |
Carling T, Imanishi Y, Gaz RD, Arnold A. Analysis of the RAD54 gene on chromosome 1p as a potential tumor-suppressor gene in parathyroid adenomas. International Journal of Cancer. 83: 80-2. PMID 10449612 DOI: 10.1002/(Sici)1097-0215(19990924)83:1<80::Aid-Ijc15>3.0.Co;2-E |
0.418 |
|
| 1999 |
Hosokawa Y, Joh T, Maeda Y, Arnold A, Seto M. Cyclin D1/PRAD1/BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocation. International Journal of Cancer. 81: 616-9. PMID 10225453 DOI: 10.1002/(Sici)1097-0215(19990517)81:4<616::Aid-Ijc18>3.0.Co;2-S |
0.393 |
|
| 1998 |
Hosokawa Y, Suzuki R, Joh T, Maeda Y, Nakamura S, Kodera Y, Arnold A, Seto M. A small deletion in the 3'-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia. International Journal of Cancer. 76: 791-6. PMID 9626342 DOI: 10.1002/(Sici)1097-0215(19980610)76:6<791::Aid-Ijc4>3.0.Co;2-T |
0.461 |
|
| 1998 |
Hosokawa Y, Arnold A. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes, Chromosomes & Cancer. 22: 66-71. PMID 9591636 DOI: 10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5 |
0.389 |
|
| 1998 |
Palanisamy N, Imanishi Y, Rao PH, Tahara H, Chaganti RS, Arnold A. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. The Journal of Clinical Endocrinology and Metabolism. 83: 1766-70. PMID 9589690 DOI: 10.1210/Jcem.83.5.4806 |
0.355 |
|
| 1998 |
Chung D, Brown S, Graeme-Cook F, Warshaw A, Seto M, Jensen R, Arnold A. Overexpression of cyclin D1 protein in pancreatic endocrine tumors Gastroenterology. 114: A448. DOI: 10.1016/S0016-5085(98)81810-6 |
0.325 |
|
| 1997 |
Tahara H, Smith AP, Gaz RD, Zariwala M, Xiong Y, Arnold A. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 12: 1330-4. PMID 9286748 DOI: 10.1359/jbmr.1997.12.9.1330 |
0.339 |
|
| 1997 |
Hosokawa Y, Gadd M, Smith AP, Koerner FC, Schmidt EV, Arnold A. Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancers. Cancer Letters. 113: 123-30. PMID 9065811 DOI: 10.1016/S0304-3835(97)04605-3 |
0.308 |
|
| 1997 |
Uchimaru K, Taniguchi T, Yoshikawa M, Asano S, Arnold A, Fujita T, Motokura T. Detection of Cyclin D1 (bcl-1, PRAD1) Overexpression by a Simple Competitive Reverse Transcription-Polymerase Chain Reaction Assay in t(11; 14)(q13; q32)-Bearing B-Cell Malignancies and/or Mantle Cell Lymphoma Blood. 89: 965-974. DOI: 10.1182/Blood.V89.3.965 |
0.333 |
|
| 1997 |
Tahara H, Arnold A. Molecular basis of hyperparathyroidism Journal of Bone and Mineral Metabolism. 15: 173-178. DOI: 10.1007/Bf02491378 |
0.475 |
|
| 1996 |
Zukerberg LR, Benedict WF, Arnold A, Dyson N, Harlow E, Harris NL. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Blood. 88: 268-76. PMID 8704183 DOI: 10.1182/Blood.V88.1.268.268 |
0.324 |
|
| 1996 |
Uchimaru K, Endo K, Fujinuma H, Zukerberg L, Arnold A, Motokura T. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation. Japanese Journal of Cancer Research : Gann. 87: 459-65. PMID 8641982 DOI: 10.1111/j.1349-7006.1996.tb00246.x |
0.353 |
|
| 1996 |
Hsi ED, Zukerberg LR, Yang WI, Arnold A. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. The Journal of Clinical Endocrinology and Metabolism. 81: 1736-9. PMID 8626826 DOI: 10.1210/JCEM.81.5.8626826 |
0.4 |
|
| 1996 |
Zukerberg L, Benedict W, Arnold A, Dyson N, Harlow E, Harris N. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1 Blood. 88: 268-276. DOI: 10.1182/blood.v88.1.268.bloodjournal881268 |
0.324 |
|
| 1995 |
Hosokawa Y, Tu T, Tahara H, Smith AP, Arnold A. Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphism. Cancer Letters. 93: 165-70. PMID 7621424 DOI: 10.1016/0304-3835(95)03805-7 |
0.338 |
|
| 1995 |
Hosokawa Y, Pollak MR, Brown EM, Arnold A. Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors Journal of Clinical Endocrinology and Metabolism. 80: 3107-3110. PMID 7593409 DOI: 10.1210/Jcem.80.11.7593409 |
0.304 |
|
| 1995 |
Gaffey MJ, Iezzoni JC, Meredith SD, Boyd JC, Stoler MH, Weiss LM, Zukerberg LR, Levine PA, Arnold A, Williams ME. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma. Human Pathology. 26: 1221-6. PMID 7590696 DOI: 10.1016/0046-8177(95)90197-3 |
0.322 |
|
| 1995 |
Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions Journal of Biological Chemistry. 270: 23589-23597. PMID 7559524 DOI: 10.1074/Jbc.270.40.23589 |
0.617 |
|
| 1995 |
Swerdlow SH, Yang WI, Zukerberg LR, Harris NL, Arnold A, Williams ME. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Human Pathology. 26: 999-1004. PMID 7545645 DOI: 10.1016/0046-8177(95)90090-X |
0.34 |
|
| 1994 |
Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene Proceedings of the National Academy of Sciences of the United States of America. 91: 709-713. PMID 8290586 DOI: 10.1073/Pnas.91.2.709 |
0.374 |
|
| 1994 |
Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 369: 669-71. PMID 8208295 DOI: 10.1038/369669A0 |
0.381 |
|
| 1994 |
Cryns VL, Rubio MP, Thor AD, Louis DN, Arnold A. p53 abnormalities in human parathyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 78: 1320-4. PMID 8200932 DOI: 10.1210/Jcem.78.6.8200932 |
0.307 |
|
| 1994 |
Bianchi S, Fabiani S, Muratori M, Arnold A, Sakaguchi K, Miki T, Brandi ML. Calcium modulates the cyclin D1 expression in a rat parathyroid cell line. Biochemical and Biophysical Research Communications. 204: 691-700. PMID 7980531 DOI: 10.1006/Bbrc.1994.2515 |
0.411 |
|
| 1994 |
Cryns VL, Thor A, Xu HJ, Hu SX, Wierman ME, Vickery AL, Benedict WF, Arnold A. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. The New England Journal of Medicine. 330: 757-61. PMID 7906387 DOI: 10.1056/NEJM199403173301105 |
0.366 |
|
| 1993 |
Motokura T, Arnold A. Cyclin D and oncogenesis. Current Opinion in Genetics & Development. 3: 5-10. PMID 8453274 DOI: 10.1016/S0959-437X(05)80334-X |
0.406 |
|
| 1993 |
Cryns VL, Alexander JM, Klibanski A, Arnold A. The retinoblastoma gene in human pituitary tumors. The Journal of Clinical Endocrinology and Metabolism. 77: 644-6. PMID 7690360 DOI: 10.1210/jcem.77.3.7690360 |
0.301 |
|
| 1993 |
Motokura T, Arnold A. PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes, Chromosomes & Cancer. 7: 89-95. PMID 7687458 DOI: 10.1002/GCC.2870070205 |
0.359 |
|
| 1992 |
Motokura T, Yi HF, Kronenberg HM, McBride OW, Arnold A. Assignment of the human cyclin D3 gene (CCND3) to chromosome 6p----q13. Cytogenetics and Cell Genetics. 61: 5-7. PMID 1387066 DOI: 10.1159/000133359 |
0.332 |
|
| 1990 |
Jameson JL, Arnold A. Clinical review 5: Recombinant DNA strategies for determining the molecular basis of endocrine disorders. The Journal of Clinical Endocrinology and Metabolism. 70: 301-7. PMID 2405001 DOI: 10.1210/jcem-70-2-301 |
0.422 |
|
| Show low-probability matches. |